Pulmonx Corporation (LUNG) Q2 2024 Earnings
LUNG·Reported July 31, 2024·After market close
Pulmonx Corporation reported Q2 2024 revenue of $20.8M, beat analyst consensus of $20.1M by $653.0K. Diluted EPS came in at $-0.39, beat the $-0.41 consensus by $0.02.
Revenue
$20.8Mbeat by $653.0K
Consensus: $20.1MDiluted EPS
$-0.39beat by $0.02
Consensus: $-0.41
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Pulmonx Corporation's Q2 2024 earnings report.
Pulmonx Corporation (LUNG) reported Q2 2024 earnings on July 31, 2024 after market close.
Pulmonx Corporation reported revenue of $20.8M and diluted EPS of $-0.39 for Q2 2024.
Revenue beat the consensus estimate of $20.1M by $653.0K. EPS beat the consensus estimate of $-0.41 by $0.02.
You can read the 10-Q periodic report (0001127537-24-000077) directly on SEC EDGAR. The filing index links above go to sec.gov.